Bahman Sadeghi Sedeh
Department of Social Medicine, Arak University of Medical Sciences, Arak, Iran
[ 1 ] - A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
[ 2 ] - A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
Co-Authors